RxWires

Drug

Htx 011

Htx 011: highest development phase Post-Market, developed by Heron Therapeutics. 13 trial records tracked on RxWires.

Highest phase
Post-Market
Developer
Heron Therapeutics

Trials

DrugPhaseIndication
HTX-011 NCT06109415Post-MarketPostoperative Pain
HTX-011 NCT03907176Phase 3Analgesia
HTX-011 NCT03974932Phase 3Analgesia
HTX-011 NCT03237481Phase 3Postoperative Pain
HTX-011 NCT03295721Phase 3Postoperative Pain
HTX-011 NCT03718039Phase 2Postoperative Pain
HTX-011 NCT03011333Phase 2Postoperative Pain
HTX-011 NCT03015532Phase 2Postoperative Pain
HTX-011 NCT03695367Phase 2Postoperative Pain
HTX-011 NCT03955211Phase 2Postoperative Pain
HTX-011 NCT02471898Phase 2Analgesia
HTX-011 NCT02504580Phase 2Postoperative Pain
HTX-011 NCT03922048Phase 2Analgesia

Latest

No recent events.

Follow Htx 011 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.

Follow free

Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.